Susquehanna Portfolio Strategies »

Kura Oncology shares owned by Susquehanna Portfolio Strategies

Quarter-by-quarter ownership of Kura Oncology (KURA) shares owned by Susquehanna Portfolio Strategies from 13F filings

Historical chart of Susquehanna Portfolio Strategies investment in Kura Oncology

Tip: Access up to 7 years of quarterly data

All positions including Kura Oncology held by Susquehanna Portfolio Strategies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kura Oncology by Susquehanna Portfolio Strategies

Quarter filed Position value Share count Share price at filing
2025-09-30 $3.0M 344k 8.85

More positions owned by Susquehanna Portfolio Strategies

Oracle Corporation (ORCL)
Apple (AAPL)
Blackrock (BLK)
Merck & Co (MRK)
Arista Networks Com Shs (ANET)
Pfizer (PFE)
Amazon (AMZN)
Simon Property (SPG)
Baker Hughes Company Cl A (BKR)
Realty Income (O)
American Express Company (AXP)
Chipotle Mexican Grill (CMG)
Vulcan Materials Company (VMC)
General Motors Company (GM)
MetLife (MET)

View all positions for Susquehanna Portfolio Strategies

Top funds holding Kura Oncology

BlackRock
BVF
Suvretta Capital Management
Vanguard Group
Armistice Capital
State Street Corporation
Prosight Management
Goldman Sachs Group
AQR Capital Management
Jacobs Levy Equity Management
Millennium Management
Geode Capital Management
Morgan Stanley
Qube Research & Technologies
Alethea Capital Management

View all funds holding Kura Oncology